Literature DB >> 8544211

Evaluation of a competitive ELISA method for the determination of Klebsiella O antigens.

M Trautmann1, A S Cross, G Reich, H Held, R Podschun, R Marre.   

Abstract

Strains of Klebsiella spp. are often inagglutinable by O-specific antisera because of the copious capsule produced by most isolates. A competitive ELISA method based on the observation that bacterial supernates containing homologous O antigen specifically inhibited the reaction of type-specific antisera with purified LPS coated on ELISA plates was used to examine the O antigen of 82 isolates of different Klebsiella species and subspecies. The O antigens O1/2ab (19 isolates), O2ab (13 isolates), O2ac (11 isolates) and O3 (16 isolates) were found to account for > 70% of the O antigenic types. Overall, 65 (79%) of the strains could be assigned to a specific O serogroup. The method is suitable for examining the role of individual O antigens in systemic klebsiella infections such as nosocomial septicaemia and pneumonia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8544211     DOI: 10.1099/00222615-44-1-44

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  10 in total

1.  O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections.

Authors:  M Trautmann; M Ruhnke; T Rukavina; T K Held; A S Cross; R Marre; C Whitfield
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

2.  Rapid and Accurate Determination of Lipopolysaccharide O-Antigen Types in Klebsiella pneumoniae with a Novel PCR-Based O-Genotyping Method.

Authors:  Chi-Tai Fang; Yun-Jui Shih; Cheng-Man Cheong; Wen-Ching Yi
Journal:  J Clin Microbiol       Date:  2015-12-30       Impact factor: 5.948

3.  Somatic serogroups, capsular types, and species of fecal Klebsiella in patients with ankylosing spondylitis.

Authors:  P Toivanen; D S Hansen; F Mestre; L Lehtonen; J Vaahtovuo; M Vehma; T Möttönen; R Saario; R Luukkainen; M Nissilä
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

4.  Protective effect of antilipopolysaccharide monoclonal antibody in experimental Klebsiella infection.

Authors:  T Rukavina; B Tícac; M Susa; N Jendrike; S Jonjíc; P Lucin; R Marre; M Doríc; M Trautmann
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

5.  Binding to and opsonophagocytic activity of O-antigen-specific monoclonal antibodies against encapsulated and nonencapsulated Klebsiella pneumoniae serotype O1 strains.

Authors:  T K Held; N R Jendrike; T Rukavina; R Podschun; M Trautmann
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

6.  Progress towards the development of Klebsiella vaccines.

Authors:  Myeongjin Choi; Sharon M Tennant; Raphael Simon; Alan S Cross
Journal:  Expert Rev Vaccines       Date:  2019-06-28       Impact factor: 5.217

7.  Klebsiella pneumoniae lipopolysaccharide O typing: revision of prototype strains and O-group distribution among clinical isolates from different sources and countries.

Authors:  D S Hansen; F Mestre; S Alberti; S Hernández-Allés; D Alvarez; A Doménech-Sánchez; J Gil; S Merino; J M Tomás; V J Benedí
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

8.  Lipopolysaccharide-mediated protection against Klebsiella pneumoniae-induced lobar pneumonia: intranasal vs. intramuscular route of immunization.

Authors:  V Yadav; S Sharma; K Harjai; H Mohan; S Chhibber
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.629

9.  Proinflammatory cytokines in antilipopolysaccharide immunity against Klebsiella infections.

Authors:  Tomislav Rukavina; Vanja Vasiljev; Brigita Ticac
Journal:  Mediators Inflamm       Date:  2005-06-09       Impact factor: 4.711

10.  Production of a Promising Biosynthetic Self-Assembled Nanoconjugate Vaccine against Klebsiella Pneumoniae Serotype O2 in a General Escherichia Coli Host.

Authors:  Zhehui Peng; Jun Wu; Kangfeng Wang; Xin Li; Peng Sun; Lulu Zhang; Jing Huang; Yan Liu; Xiaoting Hua; Yunsong Yu; Chao Pan; Hengliang Wang; Li Zhu
Journal:  Adv Sci (Weinh)       Date:  2021-05-24       Impact factor: 16.806

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.